These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9623740)

  • 41. The role of radiation therapy in Graves' ophthalmopathy.
    Chowdhury AD; Moriarty MJ
    Australas Radiol; 1996 Nov; 40(4):422-3. PubMed ID: 8996904
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Quantitative results following consecutive corticoid and radiotherapy in endocrine ophthalmopathy].
    Esser J; Molls M; Benker G
    Fortschr Ophthalmol; 1988; 85(3):323-6. PubMed ID: 3209166
    [No Abstract]   [Full Text] [Related]  

  • 43. A long-term follow-up study after retro-orbital irradiation for Graves' ophthalmopathy.
    Schaefer U; Hesselmann S; Micke O; Schueller P; Bruns F; Palma C; Willich N
    Int J Radiat Oncol Biol Phys; 2002 Jan; 52(1):192-7. PubMed ID: 11777638
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The role of radiotherapy in Graves' ophthalmopathy].
    Jaulerry C
    J Fr Ophtalmol; 2004 Sep; 27(7):825-7. PubMed ID: 15499286
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The impact of 99mTc-DTPA orbital SPECT in patient selection for external radiation therapy in Graves' ophthalmopathy.
    Szabados L; Nagy EV; Ujhelyi B; Urbancsek H; Varga J; Nagy E; Galuska L
    Nucl Med Commun; 2013 Feb; 34(2):108-12. PubMed ID: 23196678
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Perspective--Part II: radiotherapy for Graves Orbitopathy: the Columbia University experience.
    Kazim M
    Ophthalmic Plast Reconstr Surg; 2002 May; 18(3):173-4. PubMed ID: 12021645
    [No Abstract]   [Full Text] [Related]  

  • 47. [Orbit pathology and Graves' ophthalmopathy].
    Stankiewicz A
    Klin Oczna; 1997; 99(1):59-63. PubMed ID: 9379657
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Orbital irradiation for thyroid-associated orbitopathy: conventional dose, low dose or no dose?
    Perros P; Krassas GE
    Clin Endocrinol (Oxf); 2002 Jun; 56(6):689-91. PubMed ID: 12072037
    [No Abstract]   [Full Text] [Related]  

  • 49. [Treatment of Graves' ophthalmopathy with irradiation].
    Slampa P; Spurný V; Seneklová Z; Krákorová D
    Vnitr Lek; 1998 Aug; 44(8):461-3. PubMed ID: 10358449
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Subtotal thyroidectomy as a superior therapeutic principle in the treatment of endocrine ophthalmopathy: a comparison with retrobulbar irradiation and thyrostatic therapy alone].
    Grussendorf M; Horster FA; Inanc Y; Goretzki PE; Röher HD; Krüskemper HL
    Wien Klin Wochenschr; 1988 May; 100(11):355-7. PubMed ID: 3407195
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Letter: Orbital radiotherapy for the ophthalmopathy of Graves's disease.
    Donaldson SS; Bagshaw MA; Kriss JP
    N Engl J Med; 1974 Apr; 290(14):805. PubMed ID: 4406001
    [No Abstract]   [Full Text] [Related]  

  • 52. Perspective--Part III: retrobulbar irradiation in Graves orbitopathy: the Dutch experience.
    Wiersinga WM
    Ophthalmic Plast Reconstr Surg; 2002 May; 18(3):175-6. PubMed ID: 12021646
    [No Abstract]   [Full Text] [Related]  

  • 53. Graves' dermopathy and acropachy are markers of severe Graves' ophthalmopathy.
    Fatourechi V; Bartley GB; Eghbali-Fatourechi GZ; Powell CC; Ahmed DD; Garrity JA
    Thyroid; 2003 Dec; 13(12):1141-4. PubMed ID: 14751035
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Step-by-step treatment of progressive edematous-infiltrative ophthalmopathy in Graves' disease. Results of the treatment by plasmapheresis (stage II) and cobalt teletherapy of orbital tissues (stage III)].
    Pilarska K; Czekalski S; Syrenicz A; Andrzejewska W; Krzystolik Z; Przerwa D; Marzecki Z; Daniel B; Osiński W
    Endokrynol Pol; 1988; 39(5):237-44. PubMed ID: 3255604
    [No Abstract]   [Full Text] [Related]  

  • 55. Assessment of a carcinogenic risk for treatment of Graves' ophthalmopathy in dependence on age and irradiation geometry.
    Broerse JJ; Snijders-Keilholz A; Jansen JT; Zoetelief J; Klein C; Seegenschmiedt MH
    Radiother Oncol; 1999 Dec; 53(3):205-8. PubMed ID: 10660199
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Graves' ophthalmopathy and 131I therapy.
    Marcocci C; Bartalena L; Tanda ML; Manetti L; Dell'Unto E; Mazzi B; Rocchi R; Barbesino G; Pinchera A
    Q J Nucl Med; 1999 Dec; 43(4):307-12. PubMed ID: 10731781
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-term safety of orbital radiotherapy for Graves' ophthalmopathy.
    Marcocci C; Bartalena L; Rocchi R; Marinò M; Menconi F; Morabito E; Mazzi B; Mazzeo S; Sartini MS; Nardi M; Cartei F; Cionini L; Pinchera A
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3561-6. PubMed ID: 12915636
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The combined therapy of Basedow's ophthalmopathy with retrobulbar radiotherapy and i.v. immunoglobulins. The preliminary results].
    Antonelli A; Saracino A; Alberti B; Melosi A; Cartei F; Lepri A; Laddaga M; Baschieri L
    Clin Ter; 1992 Jan; 140(1):25-31. PubMed ID: 1526094
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Endoscopic orbital decompression for Graves' ophthalmopathy.
    Levy J; Puterman M; Lifshitz T; Marcus M; Segal A; Monos T
    Isr Med Assoc J; 2004 Nov; 6(11):673-6. PubMed ID: 15562804
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Graves' disease of the orbit.
    Weber AL; Dallow RL; Sabates NR
    Neuroimaging Clin N Am; 1996 Feb; 6(1):61-72. PubMed ID: 8919134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.